- Home
- ATLX vs CNTB Comparison
ATLX vs CNTB Comparison
Compare ATLX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATLX | CNTB |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2M | 93.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATLX | CNTB |
|---|---|---|
| Price | $5.04 | $2.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $8.33 |
| AVG Volume (30 Days) | 546.2K | ★ 625.5K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $180,454.00 | ★ $762,000.00 |
| Revenue This Year | $22,084.55 | N/A |
| Revenue Next Year | N/A | $453,067.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.54 | $0.51 |
| 52 Week High | $8.32 | $3.28 |
Technical Indicators
Market Signals| Indicator | ATLX | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 67.20 |
| Support Level | $4.50 | $1.49 |
| Resistance Level | $5.15 | $3.28 |
| Average True Range (ATR) | 0.48 | 0.35 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 49.35 | 72.45 |
Price Performance
Historical ComparisonAbout ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.